Literature DB >> 31420625

[Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].

H W Huang1, B Yan2, M X Shang3, L B Liu1, H Hao1, Z J Xi1.   

Abstract

OBJECTIVE: To compare the perioperative and oncologic outcomes of female patients receiving laparoscopic radical cystectomy (LRC) and open radical cystectomy (ORC).
METHODS: Retrospective review of 91 consecutive female patients with urothelial carcinoma of bladder undergoing radical cystectomy at a single academic institution from 2006 to 2017. Those female patients received open radical cystectomy were matched to the patients who underwent laparoscopic radical cystectomy by using propensity score matching in 1 ∶1 ratio. The matching factors included age, body mass index (BMI), American Society of Anesthesiologists (ASA) score, pathologic stage and pathologic nodal stage. The perioperation and oncology characteristics were compared, and Kaplan-Meier method was used to analyze the overall survival (OS), cancer specific survival (CSS) and progression-free survival (PFS) estimates. Finally, we did a sensitive analysis by using multivariable COX regression of all the patients, adjusting for the matching factors.
RESULTS: There were 65 ORC and 26 LRC patients identified in this cohort with urothelial carcinoma of bladder, the median follow-up time was 38 months (interquartile range 18-69). The age (P<0.001) and ASA scores (P=0.018) were less for LRC before being matched. There were 22 LRC and 22 ORC patients matching successfully. Before being matched, the estimate blood loss (P=0.005), transfusion rate (P<0.001) and total complications rate (P=0.015) were less for LRC, and the lymph nodes yield was greater for LRC, but there were no differences in OS (P=0.698), CSS (P=0.942) and PFS (P=0.837) between the two groups. After being matched, the estimate blood loss (P=0.009), transfusion rate (P=0.001) and total complications rate (P=0.040) were less for LRC, but there was no difference in the lymph nodes yield. Besides, there were no statistic differences in OS (P=0.432), CSS (P=0.429) and PFS (P=0.284) between the two groups. In addition, in multivariable COX regression analysis, surgical approaches (LRC/ORC) were not found to be a predictor of OS (HR 1.134, 95%CI 0.335-3.835, P=0.839), CSS (HR 1.051, 95%CI 0.234-4.719, P=0.949) and PFS (HR 0.538, 95%CI 0.138-2.095, P=0.371) of the female patients with urothelial carcinoma of bladder.
CONCLUSION: It is advantageous for laparoscopic radical cystectomy in terms of estimating blood loss, transfusion rate and complication rate. But there was no evidence that laparoscopic radical cystectomy for female patients with bladder cancer had a better oncologic prognosis than open radical cystectomy from this study.

Entities:  

Mesh:

Year:  2019        PMID: 31420625      PMCID: PMC7433492          DOI: 10.19723/j.issn.1671-167X.2019.04.018

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  24 in total

Review 1.  Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches.

Authors:  Daher C Chade; Vincent P Laudone; Bernard H Bochner; Raul O Parra
Journal:  J Urol       Date:  2010-01-18       Impact factor: 7.450

Review 2.  Lymph node metastasis in bladder cancer.

Authors:  Fredrik Liedberg; Wiking Månsson
Journal:  Eur Urol       Date:  2005-09-08       Impact factor: 20.096

3.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Prospective study comparing laparoscopic and open radical cystectomy: Surgical and oncological results.

Authors:  C Esquinas; J M Alonso; E Mateo; A Dotor; A M Martín; J F Dorado; I Arance; J C Angulo
Journal:  Actas Urol Esp (Engl Ed)       Date:  2017-06-16

5.  Comparison of hand-assisted laparoscopic and open radical cystectomy for bladder cancer.

Authors:  Sheng-Zheng Wang; Ling-Wu Chen; Yong-Hai Zhang; Wen-Wei Wang; Wei Chen; Huan-Yi Lin
Journal:  Urol Int       Date:  2010-02-17       Impact factor: 2.089

6.  Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.

Authors:  Ahmad Shabsigh; Ruslan Korets; Kinjal C Vora; Christine M Brooks; Angel M Cronin; Caroline Savage; Ganesh Raj; Bernard H Bochner; Guido Dalbagni; Harry W Herr; S Machele Donat
Journal:  Eur Urol       Date:  2008-07-18       Impact factor: 20.096

Review 7.  Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer.

Authors:  Omar M Aboumarzouk; Owen Hughes; Krishna Narahari; Tomasz Drewa; Piotr L Chlosta; Howard Kynaston
Journal:  J Endourol       Date:  2013-08-02       Impact factor: 2.942

8.  Open versus laparoscopy-assisted radical cystectomy: results of a prospective study.

Authors:  Francesco Porpiglia; Julien Renard; Michele Billia; Cesare Scoffone; Cecilia Cracco; Carlo Terrone; Roberto Mario Scarpa
Journal:  J Endourol       Date:  2007-03       Impact factor: 2.942

Review 9.  Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.

Authors:  Jakub Dobruch; Siamak Daneshmand; Margit Fisch; Yair Lotan; Aidan P Noon; Matthew J Resnick; Shahrokh F Shariat; Alexandre R Zlotta; Stephen A Boorjian
Journal:  Eur Urol       Date:  2015-09-04       Impact factor: 20.096

Review 10.  Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.

Authors:  Kun Tang; Heng Li; Ding Xia; Zhiquan Hu; Qianyuan Zhuang; Jihong Liu; Hua Xu; Zhangqun Ye
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more
  1 in total

1.  Effect of Radical Laparoscopic Surgery and Conventional Open Surgery on Surgical Outcomes, Complications, and Prognosis in Elderly Patients with Bladder Cancer.

Authors:  Jiangang Chen; Zhibo Gu; Yongsheng Pan; Yong Zhang; Donghua Gu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.